Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentina Camera

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Immunology|February 26, 2024
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosisDamiano Marastoni, Matteo Foschi, Chiara Eccher, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 25, 2024
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple SclerosisDamiano Marastoni, Ermanna Turano, Agnese Tamanti, et al.
Journal of Neuroinflammation|February 12, 2026
The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosisDamiano Marastoni, Chiara Eccher, Alessio Signori, et al.
Current Medical Research and Opinion|March 13, 2018
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistenceDiana Ferraro, Valentina Camera, Eleonora Baldi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 1, 2025
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple SclerosisDamiano Marastoni, Elisa Colato, Matteo Foschi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 VaccinationAnna G Francis, Kariem Elhadd, Valentina Camera, et al.
Multiple Sclerosis and Related Disorders|November 4, 2019
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre studyDiana Ferraro, Pietro Annovazzi, Marcello Moccia, et al.
JAMA Neurology|April 4, 2022
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseJohn J Chen, Saif Huda, Yael Hacohen, et al.
Journal of Neurology|January 8, 2026
Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorderEmine Rabia Koc, Mehmet Fatih Yetkin, Furkan Saridas, et al.
Neurology|September 4, 2025
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated DiseaseRosa Cortese, Francesco Sforazzini, Giordano Gentile, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Frontiers in Immunology|February 26, 2024
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosisDamiano Marastoni, Matteo Foschi, Chiara Eccher, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 25, 2024
Association of Levels of CSF Osteopontin With Cortical Atrophy and Disability in Early Multiple SclerosisDamiano Marastoni, Ermanna Turano, Agnese Tamanti, et al.
Journal of Neuroinflammation|February 12, 2026
The effect of cladribine tablets on intrathecal inflammation in relapsing-remitting multiple sclerosisDamiano Marastoni, Chiara Eccher, Alessio Signori, et al.
Current Medical Research and Opinion|March 13, 2018
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistenceDiana Ferraro, Valentina Camera, Eleonora Baldi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 1, 2025
Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple SclerosisDamiano Marastoni, Elisa Colato, Matteo Foschi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 VaccinationAnna G Francis, Kariem Elhadd, Valentina Camera, et al.
Multiple Sclerosis and Related Disorders|November 4, 2019
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre studyDiana Ferraro, Pietro Annovazzi, Marcello Moccia, et al.
JAMA Neurology|April 4, 2022
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseJohn J Chen, Saif Huda, Yael Hacohen, et al.
Journal of Neurology|January 8, 2026
Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorderEmine Rabia Koc, Mehmet Fatih Yetkin, Furkan Saridas, et al.
Neurology|September 4, 2025
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody-Associated DiseaseRosa Cortese, Francesco Sforazzini, Giordano Gentile, et al.
Pageof 3